-
Drug, Healthcare and Patient Safety
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Pharmacist-documented interventions during the dispensing process in a primary health care facility in Qatar
Original Research
(3184) Views (964) Full article downloads
Authors: Richard Hooper, Abdullah Adam, Nadir Kheir
Published Date November 2009
Volume 2009:1 Pages 73 - 80
DOI: http://dx.doi.org/10.2147/DHPS.S5534
Richard Hooper1, Abdullah Adam2, Nadir Kheir3
1Medical Services Department, 2Pharmacy Department, Medical Services, Qatar Petroleum, Doha, Qatar; 3Qatar University, College of Pharmacy, Doha, Qatar
Objectives: To characterize prescribing error interventions documented by pharmacists in four pharmacies in a primary health care service in Qatar.
Methods: The study was conducted in a primary health care service in the State of Qatar in the period from January to March 2008. Pharmacists in four clinics within the service used online, integrated health care software to document all clinical interventions made. Documented information included: patient’s age and gender, drug therapy details, the intervention’s details, its category, and its outcome. Interventions were categorized according to the Pharmaceutical Care Network Europe Classification of drug-related problems (DRP).
Results: The number of patients who had their prescriptions intercepted were 589 (0.71% of the total 82,800 prescriptions received). The intercepted prescriptions generated 890 DRP-related interventions (an average of 1.9% DRPs identified across the four clinics). Fifty-four percent of all interventions were classified as drug choice problems, and 42% had safety problems (dose too high, potential significant interaction). The prescriber accepted the intervention in 53% of all interventions, and the treatment was changed accordingly. Interventions as a result of transcription errors, legality and formulary issues were eliminated from this study through the use of computerized physician order entry (CPOE).
Conclusions: Documenting and analyzing interventions should be a routine activity in pharmacy practice setting in primary health care services. Educational outreach visits and other strategies can improve prescribing practices and enhance patient safety.
Keywords: pharmacists, interventions, prescribing errors
Other articles by Dr Nadir Kheir
The utility of an electronic adherence assessment device in type 2 diabetes mellitus: a pilot study of single medication
Readers of this article also read:
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Long-term use of rosuvastatin: a critical risk benefit appraisal and comparison with other antihyperlipidemics
Information technology in pharmacovigilance: Benefits, challenges, and future directions from industry perspectives
Development of indicators for identifying adverse drug events in an Indian tertiary care teaching hospital
Solid self-nanoemulsifying cyclosporin A pellets prepared by fluid-bed coating: preparation, characterization and in vitro redispersibility
Editorial
Improvement of adenoviral vector-mediated gene transfer to airway epithelia by folate-modified anionic liposomes
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
Analysis on descriptions of precautionary statements in package inserts of medicines
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
- The benefits and risks of testosterone replacement therapy: a review
- Tenofovir-associated bone density loss
- Drug design with Cdc7 kinase: a potential novel cancer therapy target
- Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses




